2018-01-31 12:20 Change in number of shares and votes in Episurf Medical On the behalf of shareholders in Episurf Medical AB (NASDAQ: EPIS B), conversions of class A shares to […]
2018-01-24 08:56 Episurf Medical will exhibit at the 4th Meeting of the Biological Knee Society, held in Sutton Coldfield, UK, on February 1-2 Episurf Medical (NASDAQ: EPIS B) will exhibit at the 4th Meeting of the Biological Knee Society, an orthopaedic […]
2018-01-24 08:52 Episurf Medical will exhibit at BVASK 2018, held in Düsseldorf, Germany, on February 2-3 Episurf Medical (NASDAQ: EPIS B) will exhibit at BVASK 2018, an orthopaedic conference held in Düsseldorf, Germany (Hyatt […]
2018-01-22 15:53 OrganoWood enters distribution agreement for the Baltic market OrganoClick’s co-owned subsidiary OrganoWood has entered into a sales and distribution agreement with Osmo Baltic for the Baltic […]
2018-01-18 13:12 Episurf Medical will attend the Arab Health 2018 conference, held in Dubai, United Arab Emirates, on January 29-February 1 Episurf Medical (NASDAQ: EPIS B) will attend the Arab Health 2018 conference, the largest healthcare gathering in the […]
2018-01-18 08:33 IRRAS introduces IRRAflowTM v 2.5 with several upgrades including an updated battery configuration San Diego, CA, USA, Laichingen, Germany and Stockholm, Sweden January 18, 2018 – IRRAS AB (NASDAQ Stockholm: IRRAS), […]
2018-01-18 08:22 Episurf Medical receives market approval in Israel and signs distribution agreement for the Israeli market Episurf Medical (NASDAQ: EPIS B) today announces that the Israeli Ministry of Health has approved Episurf Medical’s Episealer® […]
2018-01-17 17:04 Premune enters agreement with Dechra for distribution of the company's licensed products in North America In January, Premune extended its collaboration with Dechra Veterinary Products for distribution of Redonyl® Ultra on the North […]
2018-01-15 09:00 Xbrane Biopharma clarifies information regarding letter of intent with CR Pharma considering Xlucane Xbrane Biopharma (“Xbrane” or the “Company”) signed the 7th of December 2017 a non-binding letter of intent with the […]
2018-01-05 12:02 Episurf Medical will exhibit at the Freiburger Knorpeltage, held in Freiburg im Breisgau, Germany, on January 19-20 Episurf Medical (NASDAQ: EPIS B) will exhibit at the Freiburger Knorpeltage (Freiburg Cartilage Days), an orthopaedic conference held in […]
2017-12-29 14:51 Change in number of shares and votes in Episurf Medical On the behalf of shareholders in Episurf Medical AB (NASDAQ: EPIS B), conversions of class A shares to […]
2017-12-22 21:09 ABG Sundal Collier har meddelat IRRAS AB att stabiliseringsåtgärder avseende Bolagets aktier har vidtagits samt att stabiliseringsperioden avslutats The press release in its entirety can be found on the company’s homepage. Link to the press release
2017-12-22 10:02 Nomination committe of OrganoClick AB for the AGM 2018 In accordance with the resolution at OrganoClick’s Annual General Meeting (AGM) 2017, OrganoClick’s nomination committee is composed of […]
2017-12-22 09:31 Internal transaction of OrganoClicks shares in the Beijer-sphere OrganoClicks head owner, the Beijer-sphere today made an internal transaction of OrganoClick shares between the two group companies […]
2017-12-22 08:08 Serendipity Ixora proposes distribution of its Xbrane shares to its shareholders, after which Serendipity Group becomes the largest shareholder in Xbrane if the distribution is executed Xbrane Biopharma AB (publ) (“Xbrane” or “the Company”) informs that the Company’s largest shareholder Serendipity Ixora AB (“Serendipity […]
2017-12-22 08:04 Xbrane Biopharma largest shareholder Serendipity Group issues a credit facility of SEK 50 million to the company Xbrane Biopharma AB (publ) (“Xbrane” or the “Company”) has today got issued a credit facility from Serendipity Group […]
2017-12-22 08:02 OrganoClicks third largest shareholder Serendipity Ixora proposes distribution of a majority of its listed shares including OrganoClick OrganoClick informs that the Company’s third largest shareholder Serendipity Ixora AB, intends to distribute all its shares in […]
2017-12-22 07:58 Xbrane Biopharma informs about ongoing negotiations concerning out-licensing of Spherotide to China Xbrane Biopharma AB (publ) (“Xbrane” or the “Company”) continue its negotiations concerning out-licensing of sales and marketing rights […]
2017-12-19 18:37 Xbrane Biopharma signs agreement with BL&H for sales and marketing of Spherotide in South Korea Xbrane Biopharma AB (“Xbrane” or “the Company”) has signed a distribution agreement with BL&H for sales and marketing […]
2017-12-18 14:31 New patent in Australia for Episurf Medical The Australian patent office IP Australia has issued a Notice of allowance for another patent for Episurf Medical […]
2017-12-13 12:43 Xbrane Biopharma informs about changes in management team Xbrane Biopharma AB (“Xbrane” or “the Company”) announces that Carlo Colombo, Head of Production within Xbranes long acting […]
2017-12-13 07:20 IRRAS announces voluntary recall on its IRRAflow™ device due to an isolated incident of a battery manufacturing failure IRRAS AB (IRRAS), a commercial-stage medical technology company focused on designing, developing and commercializing innovative solutions for various […]
2017-12-12 08:32 Episurf Medical reaches milestone of 300 implants Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached another milestone by the planning of […]
2017-12-11 13:02 Episurf Medical’s 100th Episealer® implant in Germany Episurf Medical announces that the surgery of the 100th Episealer® implant in Germany will take place in the […]
2017-12-06 07:38 Episurf Medical will exhibit at Gelenk Kurs, held in Berlin, Germany, on December 15 Episurf Medical (NASDAQ: EPIS B) will exhibit at Gelen Kurs (Konservative und rehabilitative Aspekte bei Verletzungen der unteren Extremität), […]
2017-12-01 08:16 ABG Sundal Collier AB (”ABGSC”) har meddelat IRRAS AB (“IRRAS” eller ”Bolaget”) att stabiliseringsåtgärder avseende Bolagets aktier har vidtagits The press release in its entirety can be found on the company’s homepage. Link to the press release […]
2017-11-27 10:38 Episurf Medical will exhibit at the Basingstoke Knee Osteotomy Masterclass, held in Basingstoke, UK, on December 7-8 Episurf Medical (NASDAQ: EPIS B) will exhibit at the Basingstoke Knee Osteotomy Masterclass held in Basingstoke, UK (The […]
2017-11-23 20:35 Announcement of acquisitions of shares in IRRAS made by board members and senior management in the Company The following members of the Board of Directors and senior management in IRRAS AB (publ) (“IRRAS” or the […]
2017-11-23 09:46 Board members and senior management in IRRAS have notified their intention to acquire shares in the Company As previously announced by IRRAS AB (publ) (“IRRAS” or the “Company”), trading in the Company’s shares on Nasdaq […]
2017-11-22 09:21 Episurf Medical AB will exhibit at Frankfurt MuskuloSkelettal, held in Frankfurt am Main, Germany, on December 8-9 Episurf Medical (NASDAQ: EPIS B) will exhibit at Frankfurt MuskuloSkelettal, held in Frankfurt am Main, Germany (Maritim Hotel), […]
